Open-Label Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms Associated with High-Functioning Pervasive Developmental Disorders

Source:

Journal of Child and Adolescent Psychopharmacology, Volume 16, Issue 5, p.599-610 (2006)

Layperson Summary:

Atomoxetine may help children who have autism and attention deficit/hyperactivity disorder (ADHD).

The study was designed to see if atomoxetine can be used to treat problems with attention, hyperactivity, and impulsivity that can sometimes be found in children with pervasive developmental disorder (PDD). The study included only 17 children (ages 6-17). The children showed an improvement in the general symptoms of autism (Clinical Global Impressions Severity). They also showed some improvements in behavior (Aberrant Behavior Checklist). The authors suggest that atomoxetine may work for children who cannot take other drugs that are commonly used to treat ADHD (stimulants).

Scientific Abstract

page last updated 01/25/2007

Or subscribe to feed using a feed reader.